Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane protein MLC1 is a transmembrane protein, most highly expressed in brain astroglial cells, that fine-tunes cell junctions by regulating the strength of adhesion and possibly the transport of fluids and small molecules across the blood-brain barrier. MLC1 modulates VRAC currents, but is not a pore-forming subunit of the channel itself—instead, it acts as a regulatory accessory protein, possibly via interaction with GlialCAM and other partners. Pathogenic mutations in the gene cause most cases of megalencephalic leukoencephalopathy with subcortical cysts, a rare neurological disorder marked by macrocephaly, movement impairment, and seizures. Emerging research suggests an autoimmune role, with MLC1 as a potential antigenic target in multiple sclerosis[1][3][5][7][9].
For potential therapies, mechanisms would involve modulation of VRAC currents in astroglial cells, restoration of normal ion and fluid homeostasis, and possibly immune modulation. In autoimmune disease (multiple sclerosis), immune responses may target MLC1.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane protein MLC1 (MLC1).